SUN PHARMA Share Price

Check Sun Pharma share price, live chart and  historical price trend. Sun Pharmaceutical share is listed on BSE and NSE India, BUY-SELL trend confirmation, financial data, Sun Pharma (SUNPHARMA) profitable trading strategy and more!

Sun Pharma Share Price Trend

Sun Pharma Share Chart

Sun Pharma Trading Strategy

Catch profitable trades accurately on Sun Pharma stock using the Risological Trading Indicator.

sell trade on a normal chartsell trade with Risological trading indicator

Sun Pharma Price Target for Today / Tomorrow

  • Accurately capture profitable intraday opportunities on Sun Pharma stock with Risological Indicators.
  • Stop relying on self-proclaimed market experts or wasting money on unreliable signal services.
  • For precise price forecasts for Sun Pharma, whether for today or tomorrow, trust Risological trading indicators to effectively filter market trends and provide accurate entry and exit points.
  • This advanced trading setup not only enhances trade precision but also excels at identifying sideways markets—an essential feature for minimizing losses and maximizing your trading efficiency.
  • Take control of your trades with a proven tool designed for consistent results.
Intraday Trading

This Risological trading setup also helps you identify the sideways market with greater accuracy which is critical to avoid losses.

Sun Pharma Share Price Target for 2025, 2030

Looking for the Sun Pharma share future price target?

As a long term investor, you can maximise your profit returns in Sun Pharma by implementing this customized Risological swing trading strategy.

Share Price Target
Example of HDFC Bank share with entry, stop loss and profit targets. Get clear entry & exit levels for every stock with Risological Indicators.

Sun Pharma (SUNPHARMA): Company Overview

Sun Pharmaceutical Industries Limited, commonly known as Sun Pharma, is a leading global specialty generic pharmaceutical company headquartered in Mumbai, India. Established in 1983 by Dilip Shanghvi, the company has grown to become the world’s fourth-largest specialty generic pharmaceutical company, providing high-quality, affordable medicines to customers and patients in over 100 countries.

Historical Evolution

Sun Pharma began its operations with a focus on psychiatry products, gradually expanding its portfolio to include cardiology and gastroenterology medications. Over the years, the company has grown both organically and through strategic acquisitions, including the notable acquisition of Ranbaxy Laboratories in 2014, which significantly enhanced its global footprint and product offerings.

Global Presence

With a robust global presence, Sun Pharma operates more than 40 manufacturing facilities across five continents, supported by a multicultural workforce comprising over 50 nationalities. The company’s extensive distribution network enables it to serve markets worldwide, including North America, Europe, Asia, Africa, and Australia.

Product Portfolio

Sun Pharma offers a comprehensive range of products, including generics, branded generics, specialty pharmaceuticals, over-the-counter (OTC) products, antiretrovirals, active pharmaceutical ingredients (APIs), and intermediates. Its product portfolio covers various therapeutic areas such as psychiatry, neurology, cardiology, gastroenterology, orthopedics, ophthalmology, and nephrology.

Research and Development

Innovation is a cornerstone of Sun Pharma’s operations, with approximately 2,000 scientists engaged in R&D activities. The company invests about 7-8% of its annual revenues in R&D, focusing on the development of complex formulations, APIs, and novel drug delivery systems to address unmet medical needs.

Financial Performance

As of the fiscal year ending March 2023, Sun Pharma reported consolidated revenues of approximately ₹43,080 crore (around $5.8 billion). The company’s consistent financial growth is attributed to its diversified product portfolio, strategic acquisitions, and expansion into emerging markets.

Corporate Social Responsibility

Sun Pharma is committed to corporate social responsibility (CSR), focusing on healthcare, education, and community development initiatives. The company aims to make a positive impact on society by improving access to healthcare and supporting various social causes.

With a strong emphasis on innovation, quality, and global expansion, Sun Pharmaceutical Industries Limited continues to play a pivotal role in the global pharmaceutical landscape, delivering affordable and high-quality medicines to patients worldwide.

Sun Pharma Share Financial Data